Back
Bolt Biotherapeutics Stock Price Chart
Sponsored
BOLT
Sponsored
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
BOLT
Bolt Biotherapeutics
Last Price:
0.63
Seasonality Move:
-38.25%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BOLT is experiencing slight selling pressure.
Bolt Biotherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.63 | Buy |
20-day SMA: | 0.65 | Sell |
50-day SMA: | 0.69 | Sell |
200-day SMA: | 0.96 | Sell |
8-day EMA: | 0.63 | Sell |
20-day EMA: | 0.65 | Sell |
50-day EMA: | 0.7 | Sell |
200-day EMA: | 0.92 | Sell |
Bolt Biotherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 38.19 | Sell |
Chaikin Money Flow: | -41405 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.63 - 0.69) | Sell |
Bollinger Bands (100): | (0.62 - 0.92) | Sell |
Bolt Biotherapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Bolt Biotherapeutics Stock
Is Bolt Biotherapeutics Stock a Buy?
- Bolt Biotherapeutics share price is 0.63 while BOLT 8-day simple moving average is 0.63, which is a Buy signal.
- The stock price of BOLT is 0.63 while Bolt Biotherapeutics 20-day SMA is 0.65, which makes it a Sell.
- Bolt Biotherapeutics 50-day simple moving average is 0.69 while BOLT share price is 0.63, making it a Sell technically.
- BOLT stock price is 0.63 and Bolt Biotherapeutics 200-day simple moving average is 0.96, creating a Sell signal.
BOLT Technical Analysis vs Fundamental Analysis
Sell
48
Bolt Biotherapeutics (BOLT)
is a Sell
Is Bolt Biotherapeutics a Buy or a Sell?
-
Bolt Biotherapeutics stock is rated a Sell
The current Bolt Biotherapeutics [BOLT] share price is $0.63. The Score for BOLT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Bolt Biotherapeutics Stock Info
Market Cap:
24.11M
Price in USD:
0.63
Share Volume:
113.87K
Bolt Biotherapeutics 52-Week Range
52-Week High:
1.56
52-Week Low:
0.61
Sell
48
Bolt Biotherapeutics (BOLT)
is a Sell
Bolt Biotherapeutics Share Price Forecast
-
What is the Bolt Biotherapeutics stock price today?
The Bolt Biotherapeutics stock price is 0.63 USD today. -
Will BOLT stock go up or go down?
Bolt Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Bolt Biotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Bolt Biotherapeutics is overvalued.
Is Bolt Biotherapeutics Stock a Buy?
- Bolt Biotherapeutics share price is 0.63 while BOLT 8-day exponential moving average is 0.63, which is a Sell signal.
- The stock price of BOLT is 0.63 while Bolt Biotherapeutics 20-day EMA is 0.65, which makes it a Sell.
- Bolt Biotherapeutics 50-day exponential moving average is 0.70 while BOLT share price is 0.63, making it a Sell technically.
- BOLT stock price is 0.63 and Bolt Biotherapeutics 200-day simple moving average is 0.92, creating a Sell signal.
Fundamental Analysis of Bolt Biotherapeutics
Is Bolt Biotherapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $0.59 per share.
Technical Analysis of Bolt Biotherapeutics
Should I short Bolt Biotherapeutics stock?
- BOLT Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Bolt Biotherapeutics is a Sell
- Bolt Biotherapeutics Relative Strength Index (RSI) is 38.19, which suggest Bolt Biotherapeutics is oversold
- The Bollinger Bands (25) for Bolt Biotherapeutics is (0.63 - 0.69), which suggest Bolt Biotherapeutics is a Sell
- The Bollinger Bands (100) for Bolt Biotherapeutics is (0.62 - 0.92), which suggest Bolt Biotherapeutics is a Sell
* Bolt Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.